Aristotle Atlantic Partners, LLC Adaptive Biotechnologies Corp Transaction History

Aristotle Atlantic Partners, LLC

$3.19 Billion
Q3 2024

A detailed history of Aristotle Atlantic Partners, LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Aristotle Atlantic Partners, LLC holds 3,001,201 shares of ADPT stock, worth $19.2 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares

3,001,201

Previous 2,974,188 0.91%

Holding current value

$19.2 Million

Previous $10.8 Million 42.73%

% of portfolio

0.48%

Previous 0.35%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$3.37 - $5.12 $91,033 - $138,306	27,013 Added 0.91%	3,001,201 $15.4 Million
Q2 2024 Aug 14, 2024	SELL	$2.34 - $3.96 $42,997 - $72,765	-18,375 Reduced 0.61%	2,974,188 $10.8 Million
Q1 2024 May 15, 2024	SELL	$2.88 - $4.8 $167,388 - $278,980	-58,121 Reduced 1.91%	2,992,563 $9.61 Million
Q4 2023 Feb 14, 2024	SELL	$3.46 - $5.33 $26,026 - $40,092	-7,522 Reduced 0.25%	3,050,684 $14.9 Million
Q3 2023 Nov 14, 2023	SELL	$5.07 - $8.44 $237,047 - $394,612	-46,755 Reduced 1.51%	3,058,206 $16.7 Million
Q2 2023 Aug 14, 2023	BUY	$6.19 - $8.78 $7.41 Million - $10.5 Million	1,197,872 Added 62.81%	3,104,961 $20.8 Million
Q1 2023 May 15, 2023	BUY	$7.8 - $10.11 $206,871 - $268,137	26,522 Added 1.41%	1,907,089 $16.8 Million
Q4 2022 Feb 14, 2023	SELL	$6.26 - $9.34 $86,563 - $129,153	-13,828 Reduced 0.73%	1,880,567 $14.4 Million
Q3 2022 Nov 14, 2022	BUY	$6.5 - $12.67 $3.67 Million - $7.16 Million	565,127 Added 42.51%	1,894,395 $13.5 Million
Q2 2022 Aug 15, 2022	BUY	$6.4 - $14.73 $3.65 Million - $8.39 Million	569,856 Added 75.04%	1,329,268 $10.8 Million
Q1 2022 May 16, 2022	BUY	$10.12 - $28.9 $137,804 - $393,531	13,617 Added 1.83%	759,412 $10.5 Million
Q4 2021 Feb 14, 2022	BUY	$25.17 - $36.85 $464,663 - $680,287	18,461 Added 2.54%	745,795 $20.9 Million
Q3 2021 Nov 15, 2021	BUY	$30.02 - $39.87 $290,713 - $386,101	9,684 Added 1.35%	727,334 $24.7 Million
Q2 2021 Aug 16, 2021	BUY	$32.22 - $44.59 $4.73 Million - $6.54 Million	146,708 Added 25.7%	717,650 $29.3 Million
Q1 2021 May 17, 2021	BUY	$37.26 - $67.74 $840,660 - $1.53 Million	22,562 Added 4.11%	570,942 $23 Million
Q4 2020 Feb 16, 2021	BUY	$45.01 - $65.47 $775,747 - $1.13 Million	17,235 Added 3.24%	548,380 $32.4 Million
Q3 2020 Nov 16, 2020	BUY	$35.79 - $48.81 $694,791 - $947,548	19,413 Added 3.79%	531,145 $25.8 Million
Q2 2020 Aug 14, 2020	BUY	$24.95 - $48.38 $3.52 Million - $6.82 Million	140,891 Added 37.99%	511,732 $24.8 Million
Q1 2020 May 14, 2020	BUY	$16.96 - $34.16 $122,654 - $247,045	7,232 Added 1.99%	370,841 $10.3 Million
Q4 2019 Feb 13, 2020	BUY	$24.56 - $32.8 $7.69 Million - $10.3 Million	313,150 Added 620.6%	363,609 $10.9 Million
Q3 2019 Nov 14, 2019	BUY	$30.31 - $53.51 $1.53 Million - $2.7 Million	50,459 New	50,459 $1.56 Million

Others Institutions Holding ADPT

# of Institutions

202

Shares Held

146M

Call Options Held

68.8K

Put Options Held

42.5K

View Full List

About Adaptive Biotechnologies Corp

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $913M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

More about ADPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aristotle Atlantic Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aristotle Atlantic Partners, LLC with notifications on news.

Account

Aristotle Atlantic Partners, LLC Adaptive Biotechnologies Corp Transaction History